IP Library › Granted Patent US 11,390,653
Granted Patent B2
US 11,390,653 · App. 16/986,334 · Granted Jul 19, 2022

Amino acid-specific binder and selectively identifying an amino acid

Inventors: Jennifer A. Tullman (Germantown, MD); Zvi Kelman (Gaithersburg, MD); John P. Marino (Silver Spring, MD)
Assignee: GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE
C07K14/195C07K1/13G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,390,653
App. No.
16/986,334
Granted
Jul 19, 2022
Kind
B2
Abstract

An amino acid-specific binder selectively binds to a binding amino acid. A binder complex selectively identifies the binding amino acid and includes an adjunct attached to the amino acid-specific binder. The adjunct includes a taggant, protein, substrate, or chemical modifier. Selectively identifying an N-terminal amino acid includes anchoring a C-terminal end; contacting an N-terminal amino acid of the anchored analyte with the binder complex; selectively binding when the N-terminal amino acid includes the binding amino acid; producing, by the taggant of the tagged complex, a taggant signal; detecting the taggant signal; and identifying the N-terminal amino acid based on the taggant signal.

Claims (243)

1. A binder complex for selectively identifying an amino acid, the binder complex comprising:

an amino acid-specific binder; and

an adjunct attached to the amino acid-specific binder,

wherein the amino acid-specific binder binds selectively to a binding amino acid, and

the amino acid-specific binder comprises the amino acid sequence comprising:

a first amino acid sequence comprising X1-C-P-S-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a second amino acid sequence comprising X1-C-S-W-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a third amino acid sequence comprising X1-P-M-S-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a fourth amino acid sequence comprising X1-S-G-R-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a fifth amino acid sequence comprising X1-P-M-P-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a sixth amino acid sequence comprising X1-P-R-E-X2-V-X3-R-X4-T-X5-S-E-X6-E-X7-G-K-X8;

a seventh amino acid sequence comprising X1-P-R-E-X2-E-X3-N-X4-Q-X5-C-T-X6-Q-X7-A-R-X8;

or an eighth amino acid sequence comprising X1-P-M-S-X2-E-X3-N-X4-Q-X5-S-T-X6-Q-X7-A-R-X8;

wherein:

X1 comprises an amino acid sequence comprising

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYT (Sequence ID No. 20);

X2 comprises an amino acid sequence comprising FVT;

X3 comprises an amino acid sequence comprising VLKAVF (Sequence ID No. 21);

X4 comprises an amino acid sequence comprising MSED (Sequence ID No. 22);

X5 comprises an amino acid sequence comprising GRRVMMTAHRFGSAVVVV (Sequence ID No. 23);

X6 comprises an amino acid sequence comprising RDIAETKAK (Sequence ID No. 24);

X7 comprises an amino acid sequence comprising ATDL (Sequence ID No. 25); and

X8 comprises an amino acid sequence comprising EAGFPLMFTTEPEE (Sequence ID No. 26),

such that a total percentage amount of substitutions and deletions to X1, X2, X3, X4, X5, X6, X7, and X8 is from 0% to less than 30%, exclusive of

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMEFVTVVLKAVFRMSEDTGRRVM MTAHRFGSAVVVVCERDIAETKAKEATDLGKEAGFPLMFTTEPEE (Sequence ID No. 27), or

wherein the amino acid-specific binder comprises the amino acid sequence comprising NLEKIKKLRNVIKEIKKDNIKEADEHEKKE REKETSAWKVILYNDDIHKFSYVTDVIVKVV GQISKAKAHTITVEAHSTGQALILSTQKSKAEKYCQELQQNGLTVSIIHESQLKDKQKK (Sequence ID No. 10).

2. The binder complex of claim 1 , wherein the amino acid sequence comprises:

(Sequence ID No. 1)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTCPSFVTVVLK

AVFRMSBDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 2)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTCSWFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 3)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMSFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAWWCERDIAETKAKEATDLGK

EAGFPLMFTTEPEE;

(Sequence ID No. 4)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTSGRFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVWVCERDIAETKAKEATDLG

KEAGFPLMFTTEPEE;

(Sequence ID No. 5)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMPFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 6)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPREFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVWSERDIAETKAKEATDLG

KEAGFPLMFTTEPEE;

(Sequence ID No. 7)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPREFVTEVLK

AVFNMSEDQGRRVMMTAHRFGSAVVGVCTRDIAETKAKQATDL

AREAGFPLMFTTEPEE;

(Sequence ID No. 8)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMSFVTEVLK

AVFNMSEDQGRRVMMTAHRFGSAVVGVSTRDIAETKAKQATDL

AREAGFPLMFTTEPEE;

or

(Sequence ID No. 10)

NLEKIKKLRNVIKEIKKDNIKEADEHEKKEREKETSAWKVILY

NDDIHKFSYVTDVIVKVVGQISKAKAHTITVEAHSTGQALILS

TWKSKAEKYCQELQQNGLTVSIIHESQLKDKQKK.

3. The binder complex of claim 1 , wherein the adjunct comprises a taggant, a protein, a substrate, or a chemical modifier.

4. The binder complex of claim 3 , wherein the taggant comprises:

a fluorescent moiety, an electrochemical moiety, or a combination comprising at least one of the foregoing moieties, and

the taggant produces a taggant signal in response to receiving a stimulus.

5. A process for selectively identifying an N-terminal amino acid, the process comprising:

providing an analyte comprising a protein, a peptide, an amino acid, or a combination comprising at least one of foregoing;

contacting a C-terminal end of the analyte with an anchor;

anchoring the C-terminal end to the anchor to form an anchored analyte;

contacting an N-terminal amino acid of the anchored analyte with a binder complex, the binder complex comprising:

an amino acid-specific binder; and

a taggant attached to the amino acid-specific binder;

selectively binding the amino acid-specific binder of the binder complex to the N-terminal amino acid of the anchored analyte when the N-terminal amino acid comprises a binding amino acid to form a tagged complex;

subjecting the taggant of the tagged complex to a stimulus;

producing, by the taggant of the tagged complex, a taggant signal in response to the stimulus;

detecting the taggant signal; and

identifying the N-terminal amino acid based on the taggant signal, wherein the amino acid-specific binder binds selectively to the binding amino acid, and

the amino acid-specific binder comprises the amino acid sequence comprising:

a first amino acid sequence comprising X1-C-P-S-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a second amino acid sequence comprising X1-C-S-W-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a third amino acid sequence comprising X1-P-M-S-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a fourth amino acid sequence comprising X1-S-G-R-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a fifth amino acid sequence comprising X1-P-M-P-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a sixth amino acid sequence comprising X1-P-R-E-X2-V-X3-R-X4-T-X5-S-E-X6-E-X7-G-K-X8;

a seventh amino acid sequence comprising X1-P-R-E-X2-E-X3-N-X4-Q-X5-C-T-X6-Q-X7-A-R-X8;

or an eighth amino acid sequence comprising X1-P-M-S-X2-E-X3-N-X4-Q-X5-S-T-X6-Q-X7-A-R-X8;

wherein:

X1 comprises an amino acid sequence comprising

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYT (Sequence ID No. 20);

X2 comprises an amino acid sequence comprising FVT;

X3 comprises an amino acid sequence comprising VLKAVF (Sequence ID No. 21);

X4 comprises an amino acid sequence comprising MSED (Sequence ID No. 22);

X5 comprises an amino acid sequence comprising GRRVMMTAHRFGSAVVVV (Sequence ID No. 23);

X6 comprises an amino acid sequence comprising RDIAETKAK (Sequence ID No. 24);

X7 comprises an amino acid sequence comprising ATDL (Sequence ID No. 25); and

X8 comprises an amino acid sequence comprising EAGFPLMFTTEPEE (Sequence ID No. 26),

such that a total percentage amount of substitutions and deletions to X1, X2, X3, X4, X5, X6, X7, and X8 is from 0% to less than 30%, exclusive of SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMEFVTVVLKAVFRMSEDTGRRVM MTAHRFGSAVVVVCERDIAETKAKEATDLGKEAGFPLMFTTEPEE (Sequence ID No. 27), or

wherein the amino acid-specific binder comprises the amino acid sequence comprising NLEKIKKLRNVIKEIKKDNIKEADEHEKKEREKETSAWKVILYNDDIHKFSYVTDVIVKVV GQISKAKAHTITVEAHSTGQALILSTQKSKAEKYCQELQQNGLTVSIIHESQLKDKQKK (Sequence ID No. 10).

6. The process of claim 5 , wherein the amino acid sequence comprises:

(Sequence ID No. 1)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTCPSFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 2)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTCSWFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 3)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMSFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 4)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTSGRFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 5)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMPFVTWLKA

VFRMSEDTGRRVMMTAHRFGSAVVWCERDIAETKAKEATDLGK

EAGFPLMFTTEPEE;

(Sequence ID No. 6)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPREFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVSERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 7)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPREFVTEVLK

AVFNMSEDQGRRVMMTAHRFGSAVVGVCTRDIAETKAKQATDL

AREAGFPLMFTTEPEE;

(Sequence ID No. 8)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMSFVTEVLK

AVFNMSEDQGRRVMMTAHRFGSAVVGVSTRDIAETKAKQATDL

AREAGFPLMFTTEPEE;

or

(Sequence ID No. 10)

NLEKIKKLRNVIKEIKKDNIKEADEHEKKEREKETSAWKVILY

NDDIHKFSYVTDVIVKVVGQISKAKAHTITVEAHSTGQALILS

TWKSKAEKYCQELQQNGLTVSIIHESQLKDKQKK.

7. The process of claim 5 , further comprising:

removing the N-terminal amino acid from the anchored analyte so that a penultimate residue becomes the N-terminal amino acid of the anchored analyte;

contacting the N-terminal amino acid of the anchored analyte with the binder complex;

selectively binding the amino acid-specific binder of the binder complex to the N-terminal amino acid of the anchored analyte when the N-terminal amino acid is the binding amino acid to form the tagged complex;

subjecting the taggant of the tagged complex to the stimulus;

producing, by the taggant of the tagged complex, the taggant signal in response to the stimulus;

detecting the taggant signal; and

identifying the N-terminal amino acid based on the taggant signal.

8. The process of claim 5 , further comprising:

converting the N-terminal amino acid to an inert residue;

converting a penultimate residue to be the N-terminal amino acid when the inert residue is produced;

contacting the N-terminal amino acid of the anchored analyte with the binder complex;

selectively binding the amino acid-specific binder of the binder complex to the N-terminal amino acid of the anchored analyte when the N-terminal amino acid is the binding amino acid to form the tagged complex;

subjecting the taggant of the tagged complex to the stimulus;

producing, by the taggant of the tagged complex, the taggant signal in response to the stimulus;

detecting the taggant signal; and

identifying the N-terminal amino acid based on the taggant signal.

9. The process of claim 8 , wherein converting the N-terminal amino acid to the inert residue comprises chemically changing the N-terminal amino acid prior to producing the inert residue.

10. The process of claim 9 , wherein chemically changing the N-terminal amino acid prior to producing the inert residue comprises phosphorylating a free amine of the N-terminal amino acid.

11. A process for selectively isolating an analyte, the process comprising:

contacting an amino acid-specific binder with an analyte comprising a protein, a peptide, an amino acid, or a combination comprising at least one of foregoing;

selectively binding the amino acid-specific binder to the N-terminal amino acid of the analyte when the N-terminal amino acid comprises a binding amino acid to form an isolation complex;

separating the isolation complex from a fluid in which the isolation complex is disposed to selectively isolating the analyte,

wherein the amino acid-specific binder binds selectively to the binding amino acid, and the amino acid-specific binder comprises the amino acid sequence comprising:

a first amino acid sequence comprising X1-C-P-S-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a second amino acid sequence comprising X1-C-S-W-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a third amino acid sequence comprising X1-P-M-S-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a fourth amino acid sequence comprising X1-S-G-R-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a fifth amino acid sequence comprising X1-P-M-P-X2-V-X3-R-X4-T-X5-C-E-X6-E-X7-G-K-X8;

a sixth amino acid sequence comprising X1-P-R-E-X2-V-X3-R-X4-T-X5-S-E-X6-E-X7-G-K-X8;

a seventh amino acid sequence comprising X1-P-R-E-X2-E-X3-N-X4-Q-X5-C-T-X6-Q-X7-A-R-X8;

or an eighth amino acid sequence comprising X1-P-M-S-X2-E-X3-N-X4-Q-X5-S-T-X6-Q-X7-A-R-X8;

wherein:

X1 comprises an amino acid sequence comprising

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYT (Sequence ID No. 20);

X2 comprises an amino acid sequence comprising FVT;

X3 comprises an amino acid sequence comprising VLKAVF (Sequence ID No. 21);

X4 comprises an amino acid sequence comprising MSED (Sequence ID No. 22);

X5 comprises an amino acid sequence comprising GRRVMMTAHRFGSAVVVV (Sequence ID No. 23);

X6 comprises an amino acid sequence comprising RDIAETKAK (Sequence ID No. 24);

X7 comprises an amino acid sequence comprising ATDL (Sequence ID No. 25); and

X8 comprises an amino acid sequence comprising EAGFPLMFTTEPEE (Sequence ID No. 26),

such that a total percentage amount of substitutions and deletions to X1, X2, X3, X4, X5, X6, X7, and X8 is from 0% to less than 30%, exclusive of SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMEFVTVVLKAVFRMSEDTGRRVM MTAHRFGSAVVVVCERDIAETKAKEATDLGKEAGFPLMFTTEPEE (Sequence ID No. 27), or

wherein the amino acid-specific binder comprises the amino acid sequence comprising NLEKIKKLRNVIKEIKKDNIKEADEHEKKEREKETSAWKVILYNDDIHKFSYVTDVIVKVV GQISKAKAHTITVEAHSTGQALILSTQKSKAEKYCQELQQNGLTVSIIHESQLKDKQKK (Sequence ID No. 10).

12. The process of claim 11 , wherein the amino acid sequence comprises:

(Sequence ID No. 1)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTCPSFVTWLKA

VFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDLG

KEAGFPLMFTTEPEE;

(Sequence ID No. 2)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTCSWFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 3)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMSFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 4)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTSGRFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 5)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMPFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVCERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 6)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPREFVTVVLK

AVFRMSEDTGRRVMMTAHRFGSAVVVVSERDIAETKAKEATDL

GKEAGFPLMFTTEPEE;

(Sequence ID No. 7)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPREFVTEVLK

AVFNMSEDQGRRVMMTAHRFGSAVVGVCTRDIAETKAKQATDL

AREAGFPLMFTTEPEE;

(Sequence ID No. 8)

SDSPVDLKPKPKVKPKLERPKLYKVMLLNDDYTPMSFVTEVLK

AVFNMSEDQGRRVMMTAHRFGSAVVGVSTRDIAETKAKQATDL

AREAGFPLMFTTEPEE;

or

(Sequence ID No. 10)

NLEKIKKLRNVIKEIKKDNIKEADEHEKKEREKETSAWKVILY

NDDIHKFSYVTDVIVKVVGQISKAKAHTITVEAHSTGQAULST

WKSKAEKYCQELQQNGLTVSIIHESQLKDKQKK.

13. The process of claim 11 , wherein separating the isolation complex from the fluid in which the isolation complex is disposed comprises;

separating the isolation complex based on a size of the isolation complex relative to a size of other constituents in the fluid;

precipitating the isolation complex from the fluid;

centrifuging; or

a combination comprising at least one of the foregoing separations.

14. The process of claim 11 , wherein the amino acid-specific binder is a member of a binder complex.

15. The process of claim 14 , wherein the binder complex comprises:

the amino acid-specific binder; and

an adjunct attached to the amino acid-specific binder.

16. The process of claim 15 , wherein the adjunct comprises a taggant, a protein, a substrate, or a chemical modifier.

17. The process of claim 16 , wherein the taggant comprises:

a fluorescent moiety, an electrochemical moiety, or a combination comprising at least one of the foregoing moieties, and

the taggant produces a taggant signal in response to receiving a stimulus.

18. The process of claim 17 , further comprising:

subjecting the taggant of the isolation complex to a stimulus;

producing, by the taggant of the isolation complex, a taggant signal in response to the stimulus;

detecting the taggant signal; and

identifying the N-terminal amino acid based on the taggant signal.

19. The process of claim 17 , wherein the stimulus comprises a photon; and

the taggant signal comprises fluorescence emitted from the taggant.

20. The process of claim 11 , further comprising:

contacting the amino acid-specific binder with an adjunct to form a binder complex prior to contacting the amino acid-specific binder with the analyte.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2020
From: KELMAN, ZVI; MARINO, JOHN P.; TULLMAN, JENNIFER A.
To: GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE
Reel/Frame 054670/0056 →
Continuity (3)
Division 16395407 · Apr 26, 2019
Provisional Application 62757271 · Nov 8, 2018
Related Publication 20200385432A1 · Dec 10, 2020
Cited By (1)
US 12,275,760